Nitroxides as antioxidants: Tempol protects against EO9 cytotoxicity

Molecular and Cellular Biochemistry

Volumn 234-235, Issue , 2002, Pages 327-333

  Samuni, Ayelet M ^a   DeGraff, William ^a   Krishna, Murali C ^a   Mitchell, James B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bioreductive; EPR; Mitomycin C; Quinone; Redox cycling

Indexed keywords

5 (1 AZIRIDINYL) 3 HYDROXYMETHYL 2 (3 HYDROXY 1 PROPENYL) 1 METHYL 4,7 INDOLEDIONE; ANTIOXIDANT; HYDROGEN PEROXIDE; HYDROQUINONE; MITOMYCIN C DERIVATIVE; NITROXIDE DERIVATIVE; OXYGEN; QUINONE DERIVATIVE; SEMIQUINONE; TEMPOL; AMINE OXIDE; AZIRIDINE DERIVATIVE; INDOLE DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL HYPOXIA; CHEMICAL REACTION; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON; ELECTRON SPIN RESONANCE; HUMAN; HUMAN CELL; OXIDATION; OXIDATION REDUCTION REACTION; OXYGEN TOXICITY; PROTECTION; SPIN TRAPPING; CELL CULTURE; CELL DEATH; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; SPIN LABELING; TIME;

AZIRIDINES; CELL DEATH; CYCLIC N-OXIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMAN; INDOLES; OXIDATION-REDUCTION; TIME FACTORS; TUMOR CELLS, CULTURED; HUMANS; INDOLEQUINONES; SPIN LABELS;

EID: 4243245596     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015974126615     Document Type: Article

References (45)

1. Nitroxyl spin label contrast enhancers for magnetic resonance imaging. Studies of acute toxicity and mutagenesis
2. Cytotoxicity of commonly used nitroxide radical spin probes
3. Antimutagenicity of a low molecular weight superoxide dismutase mimic against oxidative mutagens
4. Modification of relaxation of lipid protons by molecular oxygen and nitroxides
5. Molecular Motion in Biological Membranes
6. Interactions between cells and nitroxides and their implications for their uses as biophysical probes and as metabolically responsive contrast agents for in vivo NMR
7. Electron paramagnetic resonance spin destruction methods for radical detection
8. Absolute rate constants for the reactions of some carbon-centered radicals with 2,2,6,6- Tetramethylpiperidine-N-oxyl
9. Inhibition of lipid peroxidation by spin labels. Relationships between structure and function
10. Reduction and destruction of nitroxide spin probes
11. A novel metal-free low molecular weight superoxide dismutase mimic
12. Superoxide reaction with nitroxides
13. Mechanisms of hypoxic and aerobic cytotoxicity of mitomycin C in Chinese hamster V79 cells
14. Biologically active metal-independent superoxide dismutase mimics
15. Nitroxides block DNA scission and protect cells from oxidative damage
16. 2 decomposition by peroxidases and pseudoperoxidases
17. Antioxidant activity of nitroxide radicals in lipid peroxidation of rat liver microsomes
18. Modulation of streptonigrin cytotoxicity by nitroxide SOD mimics
19. Effects of nitroxide stable radicals on juglone cytotoxicity
20. SOD-like activity of 5-membered ring nitroxide spin labels
21. Cardiac reperfusion damage prevented by a nitroxide free radical
22. A novel anti- ulcerogenic stable radical prevents gastric mucosal lesions in rats
23. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis
24. Cerebroprotective effect of stable nitroxide radicals in closed head injury in the rat
25. TEMPOL protects against lens DNA strand breaks and cataract in the X-rayed rabbit
26. Protection of mitomycin C induced skin extravasation Rauth AM, Melo T, Misra V: Bioreductive therapies: An overview of drugs and their mechanisms of action
27. Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9
28. Factors affecting sensivity to EO9 in rodent and human tumour cells in vitro: DT- diaphorase activity and hypoxia
29. Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity
30. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9
31. Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidase
32. Viability measurements in mammalian cell systems
33. Spin trapping: ESR parameters of spin adducts
34. EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models
35. Lack of myelosuppression with EO9 in human and mouse bone marrow: Correlation with low DT-diaphorase
36. Phase-II studies with EO9 in breast, colorectal, gastric, pancreatic and NSCLC
37. Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9
38. Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug EO9
39. A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer
40. Reduction of the indoloquinone anticancer drug EO9 by purified DT-diaphorase: A detailed kinetic study and analysis of metabolites
41. Involvement of NADPH: Cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging species
42. The autoxidation of the reduced forms of EO9
43. Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell lines
44. The relative importance of NADPH: Cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions
45. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide